Skip to main content

Robert Gagnon

Equibles does not estimate personal net worth.

Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IRD alerts

About Robert Gagnon

Robert Gagnon is recorded as Chief Accounting Officer at Opus Genetics, Inc. (IRD) since September 2, 2025 and CFO at Opus Genetics, Inc. (IRD). The newest filing on record that lists Robert Gagnon as CFO at Opus Genetics, Inc. (IRD) is dated March 23, 2026. Opus Genetics, Inc. reported in an 8-K filed September 2, 2025 that Robert Gagnon was appointed Chief Financial Officer and principal accounting officer, effective September 2, 2025. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.

“On August 29, 2025, Opus Genetics, Inc., a Delaware corporation (the "Company"), appointed Robert Gagnon as the Company's Chief Financial Officer and principal accounting officer, effective September 2, 2025 (the "Effective Date").”
Opus Genetics, Inc. Form 8-K, filed September 2, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

CFO, Chief Accounting Officer

2025-09-02–present

Leadership on record at Opus Genetics, Inc.

Recent activity